Bayer’s Latest Blockbuster Is Financing for Monsanto Deal: Chart

Bayer AG has lined up $57 billion in bridge financing to fund its acquisition of Monsanto Co. in the third largest loan deal on record. Bridge loans are typically replaced by long-term debt in the bond market. Bayer, which introduced aspirin as the first blockbuster drug in 1899, will become the world’s biggest supplier of seeds and pesticides with the transaction.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.